Search Results 481-490 of 17390 for Interferon

  1. News - Chris C. Fox, M.D. - Mayo Clinic

    Chris C. Fox, M.D. · News · National Doctors' Day is March 30! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International ...

  2. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

    1 in subjects with inoperable or advanced intrahepatic cholangiocarcinoma (iCCA) whose tumors harbor FGFR2 gene fusions (by FISH performed by the central ...

  3. A Study to Confirm the Effectiveness and Safety of Terlipressin for Treatment of Hepatorenal Syndrome Type 1 - Mayo Clinic

    The purpose of this study is to confirm the effectiveness and safety of terlipressin in the treatment of adult patients with hepatorenal syndrome (HRS) type 1.

  4. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to assess the integrated effect of normalization of intestinal dysbiosis through a structured semi-vegetarian dietary intervention ...

  5. Neurology - Clinical trials - Mayo Clinic

    The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...

  6. A Study to Validate 5-hydroxyindoleacetic Acid in Plasma and Urine - Mayo Clinic

    About this study. This study aims to clinically validate two new liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays for ...

  7. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...

  8. Anti-interleukin-5 therapy for severe asthma: A new therapeutic option - Mayo Clinic

    Anti-interleukin-5 therapy is approved for patients with refractory asthma with an eosinophilic phenotype. The severe asthma care team at Mayo Clinic has ...

  9. Research of Experimental COVID-19 Therapeutics Explained - Mayo Clinic News Network

    There are two main categories of experimental therapeutics: antiviral drugs and immune modulators. Antiviral Drugs. This group of drugs prevents a virus from ...

  10. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...